Flu Vaccine Market Analysis- Size, Share, Growth, Industry Demand, Forecast, Application Analysis To 2022

Published On:May 30, 2017, 10:34 am

Flu or Flu is a respiratory illness caused by a virus. It is one of a kind of a Flu Vaccinepandemic or seasonal condition which results in headache, coryza, malaise, and fever. Flu is known to be extremely contagious and is usually spread by sneezes and coughs from an infected person. The vaccine meant for flu is called flu shot or flu vaccine and is used to protect against the virus that causes Flu. One could acquire flu by coming in physical contact with an infected person. Every year, more than 200,000 individuals are infected and hospitalized from complications pertaining to flu and nearly 36,000 individuals are predicted to die due to the same.

A flu vaccine is a combination of three Flu viruses such as Flu type A with H1N1 strain of virus, Flu type A with H3N2 virus, and Flu type A with H3N2 strain of virus. The extreme symptom of flu alters across different age groups and the type of flu which has been infected. World Health Organization (WHO) says that almost 3 to 5 million individuals are susceptible to seasonal epidemics, each year. The increasing geriatric population and rising prevalence of Flu outbreak support the need for flu vaccines across the healthcare sector. A few facts about flu is nearly 5 to 20 percent of Americans will develop flu, medical experts are of the opinion that the apt method of preventing flu is to get vaccinated every year, and flu cannot be treated with antibiotics.

Download Free Sample Report @ https://www.qyresearchgroups.com/request-sample/385423

In recent years, the Flu Vaccine market has witnessed high rate of growth because of dread of an approaching pandemic. The Flu Vaccine market has developed at a CAGR of roughly 65% in the vicinity of year 2008 and 2010 because of the havoc brought about by H1N1 infection. However, H1N1 Flu antibody demand will decline due to waning threat of swine flu epidemic. Expanding innovative work activities, increasing speculation by organizations for the improvement of flu antibody, mechanical progressions in recombinant DNA innovation; the substantial number of populace with no vaccination against flu infections in rising economies; increasing medicinal services use and expanding contribution of government and non-government organizations. In expansion, geriatric populace and individuals experiencing interminable sicknesses are at higher risk of creating flu virus disease.

Global Flu Vaccine Market is actively consolidated with few major players accounting for market share like Pfizer, Sanofi-pasteur, Novartis, Changchun Bio, GSK, Abbott, CSL, Sinovac, Hualan Bio, Alephbio, CS Vaccine, Siobp, Tianyuan Bio, and Tiantan Bio. This market depending upon its applications is widely segregate parts, i.e., For Children (6 months to 3 years old), and For Adult and Children over 3 years. This segment is generally categorized into many types such as Subunit or Surface Antigen Vaccines, Live Attenuated (Cold-Adapted) Virus Vaccines, Whole Virus Vaccines, and Split Virus Vaccines. Globally this market segment covers United States, Europe, Japan, India, China, and Southeast Asia.


Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us: